U.S. regulators have approved the first drug to treat COVID-19.
Remdesivir is an antiviral medicine given through an IV.
Its maker, Gilead Sciences Inc., said Thursday that the drug is approved for people at least 12 years old who need hospitalization for their coronavirus infection. The company is calling it Veklury.
[ ALSO READ: NC continues upward trend; more than 1,200 COVID-related hospitalizations reported ]
A large U.S. study found it cut the time to recovery by five days -- from 15 days to 10 on average.
It has been authorized for use on an emergency basis since spring. It works by inhibiting a substance the virus uses to make copies of itself.
This browser does not support the video element.